ImmuPharma Market Cap

ImmuPharma has a market cap or net worth of 8.08 million as of August 15, 2025. Its market cap has increased by 12.16% in one year.

Market Cap

8.08M

Enterprise Value

7.68M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

1.62

Market Cap Chart

Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 8.08M, a decrease of -77.62%. That is a compound annual growth rate of -7.39%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	8.08M	61.03%
Dec 31, 2024	5.02M	-27.71%
Dec 29, 2023	6.94M	13.16%
Dec 30, 2022	6.13M	-62.85%
Dec 31, 2021	16.51M	-50.56%
Dec 31, 2020	33.40M	24.75%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	179.66B
GSK plc	56.72B
Haleon	32.11B
Smith & Nephew	11.81B
ConvaTec Group	4.67B
Hikma Pharmaceuticals	3.96B
Oxford Nanopore Technologies	2.04B
HUTCHMED (China)	2.01B

Market Cap Rankings